| Literature DB >> 26475962 |
Meixia Che1, Ren Wang2, Xiaoxing Li2, Hui-Yun Wang3, X F Steven Zheng4.
Abstract
Reactive oxygen species (ROS) have important roles in normal physiology and diseases, particularly cancer. Under normal physiological conditions, they participate in redox reactions and serve as second messengers for regulatory functions. Owing to aberrant metabolism, cancer cells accumulate excessive ROS, thus requiring a robustly active antioxidant system to prevent cellular damage. Superoxide dismutases (SODs) are enzymes that catalyze the removal of superoxide free radicals. There are three distinct members of this metalloenzyme family in mammals: SOD1 (Cu/ZnSOD), SOD2 (MnSOD) and SOD3 (ecSOD). SODs are increasingly recognized for their regulatory functions in growth, metabolism and oxidative stress responses, which are also crucial for cancer development and survival. Growing evidence shows that SODs are also potentially useful anticancer drug targets. This review will focus on recent research of SODs in cellular regulation, with emphasis on their roles in cancer biology and therapy.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26475962 PMCID: PMC4724522 DOI: 10.1016/j.drudis.2015.10.001
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851